Chapter 1 - Introduction

[1]        Explanatory Memorandum, National Cancer Screening Register Bill 2016 (EM), p. 1.

[2]        EM, p. 1.

[3]        EM, p. 1.

[4]        EM, pp 7–9.

[5]        EM, pp 10–13.

[6]        EM, pp 13–16.

[7]        EM, pp 22–24.

[8]        Explanatory Memorandum, National Cancer Screening Register Bill (Consequential and Transitional Provisions) 2016, p. 4.

[9]        Senate Standing Committee for the Scrutiny of Bills, Alert Digest No. 6 of 2016,
14 September 2016, p. 24.

[10]      Senate Standing Committee for the Scrutiny of Bills, Alert Digest No. 6 of 2016,
14 September 2016, p. 25.

[11]      Senate Standing Committee for the Scrutiny of Bills, Alert Digest No. 6 of 2016,
14 September 2016, p. 25.

[12]      EM, p. 5.

[13]      EM, p. 5.

[14]      EM, p. 5.

[15]      EM, p. 5.

[16]      Journals of the Senate, No. 5, Tuesday 13 September 2016, p. 173.

Chapter 2 - Key Issues

[1]        School of Public Health and Preventative Medicine, Monash University, Submission 7, [p. 1].

[2]        Victorian Cytology Service, Submission 6, p. 2.

[3]        Department of Health, Submission 22, p. 2.

[4]        Department of Health, Submission 22, p. 2.

[5]        Cancer Council Australia, Submission 14, [p. 2].

[6]        Department of Health, Submission 22, p. 2.

[7]        Explanatory Memorandum, National Cancer Screening Register Bill 2016, p. 1.

[8]        Menzies School of Health Research, Submission 11, [p. 3].

[9]        Bowel Cancer Australia, Submission 23, p. 3.

[10]      Department of Health, Submission 22, p. 6.

[11]      Mr Shane Solomon, Chief Executive Officer, Telstra Health, Committee Hansard,                   29 September 2016, p. 4.

[12]      Telstra Health, Submission 10, pp 5–7.

[13]      Mr Shane Solomon, Chief Executive Officer, Telstra Health, Committee Hansard,                   29 September 2016, p. 4.

[14]      Pathology Australia, Submission 13, p. 5.

[15]      Cancer Council Australia, Submission 14, [p. 1].

[16]      Mr Andrew Sandham, Head of Commercial Contracts, Telstra Health, Committee Hansard,    29 September 2016, p. 4.

[17]      Mr James Shaw, Director Government Relations, Telstra Health, Committee Hansard,            29 September 2016, p. 4.

[18]      Department of Health, Submission 22, p. 10.

[19]      Department of Health, Submission 22, p. 11.

[20]      Cancer Council Australia, Submission 14, [p. 2].

[21]      The Royal College of Pathologists of Australia, Submission 5, p. 2.

[22]      Ms Bobbi Campbell, Acting Deputy Secretary, Department of Health, Committee Hansard,   
29 September 2016, p. 75.

[23]      Pathology Australia, Submission 13, pp 2–3.

[24]      Professor Annabelle Farnsworth, Submission 4, [p. 2].

[25]      Associate Professor Bruce Armstrong, Submission 3, p. 2.

[26]      Mr Shane Solomon, Chief Executive Officer, Telstra Health, Committee Hansard,                   29 September 2016, p. 6.

[27]      School of Public Health and Preventative Medicine, Monash University, Submission 7, [p. 1].

[28]      Department of Health, Submission 22, p. 11.

[29]      Office of the Australian Information Commissioner, Submission 20, pp 2–3.

[30]      Office of the Australian Information Commissioner, Submission 20, p. 3.

[31]      EM, p. 11.

[32]      Office of the Australian Information Commissioner, Submission 20, p. 3.

[33]      Office of the Australian Information Commissioner, Submission 20, pp 4–5.

[34]      Office of the Australian Information Commissioner, Submission 20, p. 4.

[35]      Mr Timothy Pilgrim, Australian Privacy Commissioner and Acting Australian Information Commissioner, Office of the Australian Information Commissioner, Committee Hansard,       29 September 2016, pp 31–32.

[36]      Department of Health, answers to questions on notice, 29 September 2016 (received
5 October 2016).

Labor Senators' Additional Comments

[1]        Committee Report, paragraph 2.24.

[2]        Prof. Marion Saville, Executive Director, Victorian Cytology Service Ltd, Committee Hansard, 29 September 2016, p. 40.

[3]        Prof. Marion Saville, Executive Director, Victorian Cytology Service Ltd, Committee Hansard, 29 September 2016, p. 43.

[4]        Associate Professor Bruce Armstrong, Submission 3, p. 2.

[5]        Australian Medical Association, Submission 19, pp 1–2.

[6]        Dr Magdalena Simonis, Member, Expert Committee – Quality Care, Royal Australian College of General Practitioners, Committee Hansard, 29 September 2016, p. 21.

[7]        Senator Reynolds, Acting Chair, Committee Hansard, 29 September 2016, p. 63.

[8]        Australian Healthcare and Hospitals Association, Submission 8, p. 3.